Summary

Product

JAMP Pentoxifylline SR

Issue

Health products – Product safety

What to do

Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.

Affected products

Filter items

Showing 1 to 1 of 1 entries

Show 102550100 entries

Brand

Product Name

Market Authorization

Dosage Form

Strength

Lot

Issue

Affected lot may contain Sitagliptin 100mg tablets

What you should do

1. Verify if your product is affected.
2. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
3. Contact the recalling firm if you have any questions about the recall.
4. Report any health product related side effects to Health Canada.
5. Report any other health product safety complaints to Health Canada.

Additional information

Background

Depth of recall: Retailers

Details

Original published date: 2025-05-05

Alert / recall type

Health product recall

Category

Health products – Drugs

Companies

JAMP Pharma Corporation

1310 Rue Nobel,

Boucherville, QC,

J4B 5H3

Published by

Health Canada

Audience

General public

Healthcare

Industry

Recall class

Type III

Identification number

RA-77404